Antioxidative and Anti-Atopic Dermatitis Effects of Peptides Derived from Hydrolyzed Sebastes schlegelii Tail By-Products
Marine Drugs · 2024
DOI: 10.3390/md22100479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Sung-Gyu Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Chungcheongnam-do, Republic of Korea. Hauptthemen laut MEDLINE: Antioxidants, Dermatitis, Atopic, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Marine Science and Technology Promotion, Korea Innovation Foundation funded by Ministry of Science and ICT, Development of Technology for Bio Materialization of Marine Fisheries By-Products from the Korea Institute of Marine Science and Technology Promotion (KIMST).
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disorder associated with significant morbidity, including pruritus, recurrent skin lesions, and immune dysregulation. This study aimed to investigate the antioxidative and anti-AD effects of peptides derived from hydrolyzed Sebastes schlegelii (Korea rockfish) tail by-products. Hydrolysates were prepared using various enzymes, including Alcalase, Flavourzyme, Neutrase, and Protamex. Among them, Protamex hydrolysates demonstrated the highest ABTS radical scavenging activity with an RC50 value of 69.69 ± 0.41 µg/mL. Peptides were further isolated from the Protamex hydrolysate using dialysis, fast protein liquid chromatography (FPLC), and high-performance liquid chromatography (HPLC). The most active peptide, STPO-B-II, exhibited a single peak and was identified as a sequence of Glu-Leu-Ala-Lys-Thr-Trp-His-Asp-Met-Lys, designated as MP003. In vivo experiments were conducted using a 2,4-dinitrochlorbenzene (DNCB)-induced AD model in NC/Nga mice. The isolated peptide, MP003, showed significantly reduced AD symptoms, including erythema, lichenification, and collagen deposition. Additionally, MP003 decreased epidermal and dermal thickness, eosinophil, and mast cell infiltration and downregulated the expression of pro-inflammatory cytokines IL-1β, IL-6, and IgE in serum and skin tissues. These findings suggest that peptides derived from Sebastes schlegelii tail by-products may serve as potential therapeutic agents for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Chungcheongnam-do, Republic of Korea.
- Marine Bio-Food and Drug Convergence Technology Center, Dankook University, Cheonan-si 31116, Chungcheongnam-do, Republic of Korea.
Förderung
- Korea Institute of Marine Science and Technology Promotion
- Korea Innovation Foundation funded by Ministry of Science and ICT
- Development of Technology for Bio Materialization of Marine Fisheries By-Products from the Korea Institute of Marine Science and Technology Promotion (KIMST)
- Ministry of Oceans and Fisheries
- Ministry of Trade, Industry & Energy (MOTIE)
- Ministry of Science and ICT
Zitieren
APA
Lee, S. G., Hwang, J. W., & Kang, H. (2024). Antioxidative and Anti-Atopic Dermatitis Effects of Peptides Derived from Hydrolyzed Sebastes schlegelii Tail By-Products. Marine Drugs. https://doi.org/10.3390/md22100479
Vancouver
Lee SG, Hwang JW, Kang H. Antioxidative and Anti-Atopic Dermatitis Effects of Peptides Derived from Hydrolyzed Sebastes schlegelii Tail By-Products. Marine Drugs. 2024. doi:10.3390/md22100479
BibTeX
@article{Lee2024,
author = {Lee, Sung-Gyu and Hwang, Jin-Woo and Kang, Hyun},
title = {Antioxidative and Anti-Atopic Dermatitis Effects of Peptides Derived from Hydrolyzed Sebastes schlegelii Tail By-Products},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22100479}
}
EUVIMED